{"DataElement":{"publicId":"4616412","version":"1","preferredName":"International Neuroblastoma Pathology Classification Mitosis Karyorrhexis Index Category","preferredDefinition":"Text term that represents the component of the International Neuroblastoma Pathology Classification (INPC) for mitosis-karyorrhexis index (MKI).","longName":"3521379v1.0:4616411v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3521379","version":"1","preferredName":"Neuroblastoma International Neuroblastoma Pathology Classification Histology","preferredDefinition":"Neuroblastoma is a specific type of neuroblastic tumor which is characterized by the presense of neuroblastic cells forming groups or nests separated by delicate stromal septa without prominent Schwannian stroma. (Adapted from WHO.)_A classification system established by adopting the original system proposed by Shimada with subsequent revisions. The INPC distinguishes favorable and unfavorable histology groups._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","longName":"2961432v1.0:3521377v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2961432","version":"1","preferredName":"Neuroblastoma","preferredDefinition":"Neuroblastoma is a specific type of neuroblastic tumor which is characterized by the presense of neuroblastic cells forming groups or nests separated by delicate stromal septa without prominent Schwannian stroma. (Adapted from WHO.)","longName":"C3270","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neuroblastoma","conceptCode":"C3270","definition":"A malignant neuroblastic tumor characterized by the presence of neuroblastic cells, the absence of ganglion cells, and the absence of a prominent Schwannian stroma formation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"78A9872E-E000-5A53-E040-BB89AD437199","latestVersionIndicator":"Yes","beginDate":"2009-11-18","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-11-18","modifiedBy":"ONEDATA","dateModified":"2009-11-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3521377","version":"1","preferredName":"International Neuroblastoma Pathology Classification Histology","preferredDefinition":"A classification system established by adopting the original system proposed by Shimada with subsequent revisions. The INPC distinguishes favorable and unfavorable histology groups.:The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","longName":"C102562:C16681","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"International Neuroblastoma Pathology Classification","conceptCode":"C102562","definition":"A classification system established by adopting the original system proposed by Shimada with subsequent revisions. The INPC distinguishes favorable and unfavorable histology groups.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Histology","conceptCode":"C16681","definition":"The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C4695DE6-BAF3-D5C8-E040-BB89AD430E9C","latestVersionIndicator":"Yes","beginDate":"2012-07-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-07-09","modifiedBy":"ONEDATA","dateModified":"2012-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C4695DE6-BB04-D5C8-E040-BB89AD430E9C","latestVersionIndicator":"Yes","beginDate":"2012-07-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-07-09","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Reviewed and approved for release by T.Davidsen. mc 7/24/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4616411","version":"1","preferredName":"International Neuroblastoma Pathology Classification Mitosis-Karyorrhexis Index Category","preferredDefinition":"A grouping of items based on some commonality or by user defined characteristics.","longName":"4616411v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"15","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Intermediate","valueDescription":"Intermediate (2-4% or 100-<200/5,000 cells)","ValueMeaning":{"publicId":"3521365","version":"1","preferredName":"Intermediate (2-4% or 100-<200/5,000 cells)","longName":"3521365","preferredDefinition":"An index used in neuroblastic tumors indicating the presence of between 100 and 200 mitoses and karyorrhexis per 5,000 cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intermediate Mitosis-Karyorrhexis Index","conceptCode":"C118957","definition":"An index used in neuroblastic tumors indicating the presence of between 100 and 200 mitoses and karyorrhexis per 5,000 cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C46A2FC1-1151-C0B2-E040-BB89AD432EAC","latestVersionIndicator":"Yes","beginDate":"2012-07-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-07-09","modifiedBy":"COOPERM","dateModified":"2018-02-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"092C4992-DD2D-D246-E050-BB89AD4357E1","beginDate":"2012-07-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-01","modifiedBy":"ONEDATA","dateModified":"2014-12-01","deletedIndicator":"No"},{"value":"Low","valueDescription":"Low (<2% or <100/5,000 cells)","ValueMeaning":{"publicId":"3521366","version":"1","preferredName":"Low (<2% or <100/5,000 cells)","longName":"3521366","preferredDefinition":"An index used in neuroblastic tumors indicating the presence of less than 100 mitoses and karyorrhexis per 5,000 cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Low Mitosis-Karyorrhexis Index","conceptCode":"C118955","definition":"An index used in neuroblastic tumors indicating the presence of less than 100 mitoses and karyorrhexis per 5,000 cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C46A2FC1-1174-C0B2-E040-BB89AD432EAC","latestVersionIndicator":"Yes","beginDate":"2012-07-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-07-09","modifiedBy":"COOPERM","dateModified":"2018-02-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"092C4992-DD19-D246-E050-BB89AD4357E1","beginDate":"2012-07-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-01","modifiedBy":"ONEDATA","dateModified":"2014-12-01","deletedIndicator":"No"},{"value":"High","valueDescription":"High (>4% or >200/5,000 cells)","ValueMeaning":{"publicId":"3521364","version":"1","preferredName":"High (>4% or >200/5,000 cells)","longName":"3521364","preferredDefinition":"An index used in neuroblastic tumors indicating the presence of more than 200 mitoses and karyorrhexis per 5,000 cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"High Mitosis-Karyorrhexis Index","conceptCode":"C118958","definition":"An index used in neuroblastic tumors indicating the presence of more than 200 mitoses and karyorrhexis per 5,000 cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C46A2FC1-112E-C0B2-E040-BB89AD432EAC","latestVersionIndicator":"Yes","beginDate":"2012-07-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-07-09","modifiedBy":"COOPERM","dateModified":"2018-02-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"092C4992-DD41-D246-E050-BB89AD4357E1","beginDate":"2012-07-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-01","modifiedBy":"ONEDATA","dateModified":"2014-12-01","deletedIndicator":"No"},{"value":"Not Reported","valueDescription":"Not Reported","ValueMeaning":{"publicId":"2572578","version":"1","preferredName":"Not Reported","longName":"2572578","preferredDefinition":"Not provided or available.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Reported","conceptCode":"C43234","definition":"Not provided or available.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E88F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-12-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-12-30","modifiedBy":"DWARZEL","dateModified":"2018-03-26","changeDescription":"03/09/2011 - tc - Updated with concept code.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6547FAA6-76BE-031C-E053-F662850AAC7F","beginDate":"2018-02-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-15","modifiedBy":"ONEDATA","dateModified":"2018-02-15","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2572577","version":"1","preferredName":"Unknown","longName":"2572577","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E88E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-12-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-12-30","modifiedBy":"COLBERTM","dateModified":"2023-09-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5A064780-D6B6-6233-E053-F662850AB617","beginDate":"2017-09-25","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2017-09-25","modifiedBy":"ONEDATA","dateModified":"2017-09-25","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2433877","version":"1","preferredName":"Category","preferredDefinition":"Category; used informally to mean a class of things.","longName":"C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"062E16DD-4D2F-16F1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-28","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-28","modifiedBy":"ONEDATA","dateModified":"2005-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"092C4992-DCF9-D246-E050-BB89AD4357E1","latestVersionIndicator":"Yes","beginDate":"2014-12-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-01","modifiedBy":"COOPERM","dateModified":"2018-02-15","changeDescription":"Created to replace coded values with character terms as part of TARGET harmonization project per request by T. Davidsen. mc 12/1/2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5428034","version":"1","longName":"Clinical","context":"GDC","ClassificationSchemeItems":[{"publicId":"10000695","version":"1","longName":"Diagnosis","context":"GDC"}]},{"publicId":"5650570","version":"1","longName":"TARGET","context":"OCG","ClassificationSchemeItems":[{"publicId":"5650574","version":"1","longName":"NBL","context":"OCG"}]},{"publicId":"5806857","version":"1","longName":"HCMI (Human Cancer Models Initiative)","context":"OCG","ClassificationSchemeItems":[{"publicId":"5806867","version":"1","longName":"Neuroblastoma","context":"OCG"}]}],"AlternateNames":[{"name":"OCG","type":"USED_BY","context":"OCG"},{"name":"INCP_mitosis_karyorrhexis_index","type":"HCMI Name","context":"OCG"},{"name":"GDC","type":"USED_BY","context":"GDC"},{"name":"mitosis_karyorrhexis_index","type":"GDC_Name","context":"GDC"}],"ReferenceDocuments":[{"name":"Mitosis Karyorrhexis Index (M","type":"Preferred Question Text","description":"Mitosis Karyorrhexis Index (MKI) (Revised INPC)","url":null,"context":"NCIP"},{"name":"TARGET Instruction","type":"NOTE","description":"If INPC MKI is missing, then this is Shimada MKI.  When multiple nodules present in a single Ganglioneuroblastoma, nodular tumor, the higher MKI value is reported.","url":null,"context":"NCIP"},{"name":"HCMI Question Text","type":"Alternate Question Text","description":"International Neuroblastoma Pathology Classification Mitosis-Karyorrhexis Index","url":null,"context":"OCG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"092C5E19-764A-404A-E050-BB89AD4351DE","latestVersionIndicator":"Yes","beginDate":"2014-12-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-01","modifiedBy":"COOPERM","dateModified":"2018-02-15","changeDescription":"Created as part of TARGET harmonization project as requested by T.Davidsen. mc 12/1/2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}